1. Home
  2. RNTX vs OKYO Comparison

RNTX vs OKYO Comparison

Compare RNTX & OKYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RNTX
  • OKYO
  • Stock Information
  • Founded
  • RNTX 2001
  • OKYO 2007
  • Country
  • RNTX United States
  • OKYO United Kingdom
  • Employees
  • RNTX N/A
  • OKYO N/A
  • Industry
  • RNTX Biotechnology: Pharmaceutical Preparations
  • OKYO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • RNTX Health Care
  • OKYO Health Care
  • Exchange
  • RNTX Nasdaq
  • OKYO Nasdaq
  • Market Cap
  • RNTX 44.2M
  • OKYO 37.0M
  • IPO Year
  • RNTX N/A
  • OKYO 2022
  • Fundamental
  • Price
  • RNTX $1.72
  • OKYO $1.48
  • Analyst Decision
  • RNTX
  • OKYO Strong Buy
  • Analyst Count
  • RNTX 0
  • OKYO 1
  • Target Price
  • RNTX N/A
  • OKYO $7.00
  • AVG Volume (30 Days)
  • RNTX 27.4K
  • OKYO 87.9K
  • Earning Date
  • RNTX 05-19-2025
  • OKYO 05-16-2025
  • Dividend Yield
  • RNTX N/A
  • OKYO N/A
  • EPS Growth
  • RNTX N/A
  • OKYO N/A
  • EPS
  • RNTX N/A
  • OKYO N/A
  • Revenue
  • RNTX N/A
  • OKYO N/A
  • Revenue This Year
  • RNTX N/A
  • OKYO N/A
  • Revenue Next Year
  • RNTX N/A
  • OKYO N/A
  • P/E Ratio
  • RNTX N/A
  • OKYO N/A
  • Revenue Growth
  • RNTX N/A
  • OKYO N/A
  • 52 Week Low
  • RNTX $1.35
  • OKYO $0.81
  • 52 Week High
  • RNTX $4.40
  • OKYO $1.74
  • Technical
  • Relative Strength Index (RSI)
  • RNTX N/A
  • OKYO 57.11
  • Support Level
  • RNTX N/A
  • OKYO $1.43
  • Resistance Level
  • RNTX N/A
  • OKYO $1.65
  • Average True Range (ATR)
  • RNTX 0.00
  • OKYO 0.13
  • MACD
  • RNTX 0.00
  • OKYO 0.01
  • Stochastic Oscillator
  • RNTX 0.00
  • OKYO 59.65

About RNTX Rein Therapeutics Inc. Common Stock

Rein Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on developing therapies in orphan pulmonary and fibrosis indications, including two Phase 2-ready clinical assets. The company's product candidate includes LTI-03, LTI-01, and others.

About OKYO OKYO Pharma Limited

OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.

Share on Social Networks: